Financials

  • Market Capitalization 7.67 M
  • Employee 6
  • Founded 2016
  • CEO N/A
  • Website www.alzamend.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZMXG7M8
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4802
CNSP
CNS Pharmaceuticals, Inc. - Common Stock
5.78 USD+4.71%+0.70%+0.52%-6.77%8.45 M USD
4806
SNGX
Soligenix, Inc. - Common Stock
0.38 USD0.00%-7.32%0.00%-66.37%8.27 M USD
4821
ACXP
Acurx Pharmaceuticals, Inc. - Common Stock
1.45 USD+0.69%+2.84%0.00%-24.48%7.64 M USD
4822
ENSC
Ensysce Biosciences, Inc. - Common Stock
0.39 USD-2.50%+8.33%+56.00%+1.96%7.59 M USD

Notizie